Sectors

KVUE
Kenvue Inc.
17.08
4 x 17.14
28 x 17.15
bid
ask
-
0.11
0.64%
10:13 AM
timesize
Ytd -0.99%
1y -28.48%
17.07
day range
17.36
14.11
52 week range
24.18
Open 17.24 Prev Close 17.19 Low 17.07 High 17.36 Mkt Cap 32.81B
Vol 1.64M Avg Vol 23.36M EPS 0.84 P/E 20.35 Forward P/E 13.89
Beta 0.52 Short Ratio 3.14 Inst. Own 95.28% Dividend 0.83 Div Yield 4.75
Ex Div Date 05-13 Earning 08-06 50-d Avg 17.48 200-d Avg 17.72 1yr Est 19.50
Earning
Date For Estimate Reported Surprise surprise %
2026-05-07 2026-03 0.27 0.32 0.05 18.52%
2026-02-17 2025-12 0.22 N/A N/A N/A
2026-02-17 2025-12 0.22 0.27 0.05 22.73%
2025-11-03 2025-09 0.27 N/A N/A N/A
2025-11-03 2025-09 0.27 0.28 0.01 3.70%
2025-08-07 2025-06 0.28 0.29 0.01 3.57%
Upgrade / Downgrade
Date Firm Action From To
2026-04-15 Citigroup Upgrade Neutral Neutral
2026-04-14 Barclays Upgrade Equal-Weight Equal-Weight
2026-04-07 UBS Upgrade Neutral Neutral
2026-03-06 Barclays Upgrade Equal-Weight Equal-Weight
2026-02-18 Canaccord Genuity Upgrade Hold Hold
2026-02-18 Citigroup Upgrade Neutral Neutral
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
Date Name Relation Quantity Description
2026-03-09 ALVARADO LUANI Chief Operating Officer 61.42K Conversion of Exercise of derivative security
2026-03-09 LAWSON CARLTON Officer 111.42K Conversion of Exercise of derivative security
2025-03-04 MEURER JAN Officer 33.18K Conversion of Exercise of derivative security
2025-03-04 MONGON THIBAUT Chief Executive Officer 216.47K Conversion of Exercise of derivative security
2025-12-14 PERRY KIRK L Chief Executive Officer 62.55K Conversion of Exercise of derivative security
2025-03-04 RUH PAUL Chief Financial Officer 56.20K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 145.30M 2.50B 7.57%
2026-03-30 Vanguard Capital Management LLC 124.42M 2.14B 6.48%
2025-12-30 State Street Corporation 118.87M 2.04B 6.19%
2025-12-30 FMR, LLC 94.11M 1.62B 4.90%
2026-03-30 Vanguard Portfolio Management LLC 92.46M 1.59B 4.82%
2025-12-30 Massachusetts Financial Services Co. 68.49M 1.18B 3.57%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 60.21M 1.03B 3.14%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 48.31M 830.17M 2.52%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 41.70M 716.60M 2.17%
2026-03-30 iShares Trust-iShares Core S&P 500 ETF 24.63M 423.24M 1.28%
2026-03-30 Fidelity Concord Street Trust-Fidelity 500 Index Fund 24.47M 420.50M 1.27%
2026-04-29 SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust 22.93M 394.13M 1.19%
Dividend
Dividend Date
0.2075 2026-05-13
0.2075 2026-02-11
0.2075 2025-11-12
0.2075 2025-08-13
0.205 2025-05-14
0.205 2025-02-12